Safety Concerns with Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication

Today, the U.S. Food and Drug Administration issued a Safety Communication on “Safety Concerns with Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment.” The FDA is informing patients, caregivers, MR technologists, and health care providers of important safety precautions to help patients with implantable infusion pumps safely have an MRI exam.

Thank you.
Center for Devices and Radiological Health
Food and Drug Administration